David Kavanagh

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Venues

Blood

Clinical journal of the American Society of Nephrology : CJASN

Seminars in immunopathology

Human mutation

Newcastle University

Newcastle University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Newcastle University Dec 01 2016

United Kingdom

Professor of Complement Therapeutics :: National Renal Complement Therapeutics Centre

Newcastle University

United Kingdom

Senior Lecturer :: Nephrology

University of Edinburgh

United Kingdom

Kidney Research UK post-doctoral Clinical Research :: Chemistry

Washington University in Saint Louis

United States

Clinical Fellow :: Rheumatology

Newcastle University

United Kingdom

Clinical research Fellow :: Nephrology

NHS Greater Glasgow and Clyde

United Kingdom

SHO III :: Nephrology

Freeman Hospital

United Kingdom

SHO :: Medicine

NHS Greater Glasgow and Clyde

United Kingdom

PRHO :: Medicine

Education History

Newcastle University

United Kingdom

PHD :: Renal Genetics

University of Glasgow

United Kingdom

BSC :: Immunology

Publications

Vicky Brocklebank, Patrick R Walsh, Kate Smith-Jackson, Thomas M Hallam, Kevin J Marchbank, Valerie Wilson, Theophile Bigirumurame, Tina Dutt, Emma K Montgomery, Michal Malina, Edwin Ks Wong, Sally Johnson, Neil Sheerin, David Kavanagh
Atypical haemolytic uraemic syndrome in the era of terminal complement inhibition- An observational cohort study. Blood (2023)
Nikolaos Tzoumas, David Kavanagh, Heather J Cordell, Andrew J Lotery, Praveen J Patel, David H W Steel
Rare complement factor I variants associated with reduced macular thickness and age-related macular degeneration in the UK Biobank. Human molecular genetics 31 (16) (2022)
Gemma L Thompson, David Kavanagh
Diagnosis and treatment of thrombotic microangiopathy. International journal of laboratory hematology (2022)
Sarah Henderson, Rosalyn Ardill, Ben Christopher Reynolds, David Kavanagh
Use of a B-cell depleting regimen for antifactor H autoantibody-mediated membranoproliferative glomerulonephritis in a paediatric patient. BMJ case reports 15 (4) (2022)
Edwin K S Wong, Kevin J Marchbank, Hannah Lomax-Browne, Isabel Y Pappworth, Harriet Denton, Katie Cooke, Sophie Ward, Amy-Claire McLoughlin, Grant Richardson, Valerie Wilson, Claire Louise Harris, B Paul Morgan, Svetlana Hakobyan, Paul McAlinden, Daniel P Gale, Heather Maxwell, Martin Christian, Roger Malcomson, Timothy H J Goodship, Stephen D Marks, Matthew Caleb Pickering, David Kavanagh, H Terence Cook, Sally A Johnson, null null
C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and Outcomes. Clinical journal of the American Society of Nephrology : CJASN 16 (11) (2021)
Adnan H Khan, Janice Sutton, Angela Jane Cree, Samir Khandhadia, Gabriella De Salvo, John Tobin, Priya Prakash, Rashi Arora, Winfried M Amoaku, Peter Charbel Issa, Robert E MacLaren, Paul N Bishop, Tunde Peto, Quresh Mohamed, David H W Steel, Sobha Sivaprasad, Clare Bailey, Geeta Menon, David Kavanagh, Andrew John Lotery
Prevalence and phenotype associations of complement factor I mutations in geographic atrophy. Human mutation 42 (9) (2021)
Christoph Q Schmidt, Hubert Schrezenmeier, David Kavanagh
Complement and the prothrombotic state. Blood (2021)
Edvinas Cerniauskas, Marzena Kurzawa-Akanbi, Long Xie, Dean Hallam, Marina Moya Molina, Kathryn White, David H W Steel, Mary K Doherty, Phillip D Whitfield, Jumana Al-Aama, Lyle Armstrong, David Kavanagh, John D Lambris, Viktor I Korolchuk, Claire Harris, Majlinda Lako
Complement modulation reverses pathology in Y402H-retinal pigment epithelium cell model of age-related macular degeneration by restoring lysosomal function. Stem cells translational medicine 9 (12) (2020)
Christopher James Arthur Duncan, Benjamin J Thompson, Rui Chen, Gillian I Rice, Florian Gothe, Dan F Young, Simon C Lovell, Victoria G Shuttleworth, Vicky Brocklebank, Bronte Corner, Andrew J Skelton, Vincent Bondet, Jonathan Coxhead, Darragh Duffy, Cecile Fourrage, John H Livingston, Julija Pavaine, Edmund Cheesman, Stephania Bitetti, Angela Grainger, Meghan Acres, Barbara A Innes, Aneta Mikulasova, Ruyue Sun, Rafiqul Hussain, Ronnie Wright, Robert Wynn, Mohammed Zarhrate, Leo A H Zeef, Katrina Wood, Stephen M Hughes, Claire Louise Harris, Karin R Engelhardt, Yanick J Crow, Richard E Randall, David Kavanagh, Sophie Hambleton, Tracy A Briggs
Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2. Science immunology 4 (42) (2020)
Amy J Osborne, Matteo Breno, Nicolo Ghiringhelli Borsa, Fengxiao Bu, Véronique Frémeaux- Bacchi, Daniel P Gale, Lambertus P van den Heuvel, David Kavanagh, Marina Noris, Sheila Pinto, Pavithra M Rallapalli, Guiseppe Remuzzi, Santiago Rodríguez de Córdoba, Angela Ruiz, Richard J H Smith, Paula Vieira-Martins, Elena Volokhina, Valerie Wilson, Timothy H J Goodship, Stephen J Perkins
Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy. Journal of immunology (Baltimore, Md. : 1950) 200 (7) (2018)
Edwin K S Wong, David Kavanagh
Diseases of complement dysregulation-an overview. Seminars in immunopathology 40 (1) (2018)

David Kavanagh.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David Kavanagh